Background {#Sec1}
==========

The World Health Organization (WHO), the US Centers for Disease Control and Prevention (CDC) and the UK Department of Health have indicated *Klebsiella pneumoniae* as one of the multi drug resistant (MDR) microorganisms constituting an immediate threat for human health \[[@CR1]--[@CR3]\]*. K. pneumoniae*, an opportunistic pathogen, has emerged not only thanks to its ability to accumulate multiclass antibiotic resistance determinants over time \[[@CR1]\] but also, as widely reported, to its adeptness in causing severe community- and hospital-associated infections \[[@CR4]--[@CR6]\].

*K. pneumoniae* "permeability" to mobile genetic elements is a key factor for its dissemination not only with respect to the possibility of becoming resistant to antibiotics, but also of evolving towards more virulent phenotypes thanks to genes that may provide a survival benefit to microorganisms \[[@CR7], [@CR8]\]. However, in *K. pneumoniae* the relation between resistance and virulence is a complex issue since a systematic understanding of its population structure is still lacking \[[@CR4], [@CR9]\]. This makes it difficult to perceive the emergence of new clones, what instead could be an advantageous approach to develop epidemiological surveillance programs and avoid outbreaks, particularly of strains which have become resistant to carbapenem (carbapenem-resistant *K. pneumoniae*, CR-Kp) \[[@CR9]--[@CR11]\].

The existing body of research on carbapenem-resistance mechanisms suggests that the production of *K. pneumoniae* carbapenemase (KPC) encoded by the plasmidic gene *bla*KPC is the most common one and its rapid dissemination has typically been caused by the clonal expansion of clonal complex (CC) 258 strains, including ST258 and ST512 \[[@CR12]--[@CR16]\]. In Italy, the first KPC-positive *K. pneumoniae,* belonging to ST258, was isolated in Florence in 2008 \[[@CR17]\]. Since then, the diffusion of these strains has been evident. In fact, the last European Antimicrobial Resistance Surveillance Network report has confirmed an average prevalence of CR-Kp of up to 33.9%, percentages that make Italy an endemic country for this microorganism \[[@CR18], [@CR19]\].

To date, although some research has been carried out on the diffusion and genetic characteristics of KPC-positive *K. pneumoniae* in our region (Sicily, Italy), no single study exists which has comprehensively described these strains considering all of the Hospital's Departments for a period longer than 1 year \[[@CR20]--[@CR24]\].

In this study, we fully sequenced 50 *K. pneumoniae* strains, both carbapenem resistant and -susceptible, collected from March 2014 to March 2016 at the Laboratory of Bacteriology of the Department of Sciences for Health Promotion and Mother-Child Care "G. D'Alessandro" (Paolo Giaccone Polyclinic University Hospital, University of Palermo, Italy).

The primary aim of this study was to take a current snapshot of the distribution of *K. pneumoniae* in our geographic area by: 1) characterizing the virulome and resistome of CR-Kp clones; 2) assessing the extent to which virulence determinants were carried by CR-Kp and CS-Kp (carbapenem susceptible *K. pneumoniae*); 3) investigating the phylogenetic correlations among samples by Multilocus sequence typing (MLST) in silico and the analysis of core single nucleotide polymorphisms (SNPs).

Methods {#Sec2}
=======

Bacterial strains and antimicrobial susceptibility testing {#Sec3}
----------------------------------------------------------

Species and antimicrobial susceptibility were determined using the Becton- Dickinson Phoenix™ automated system (Becton Dickinson, Sparks, MD, USA). Resistance to carbapenem was established by interpreting the results of the antimicrobial susceptibility test on the basis of the breakpoint criteria of the European Committee on Antimicrobial Susceptibility Testing \[[@CR25]\]. On the base of carbapenem susceptibility the 50 strains were divided in 25 isolates resistant (CR-Kp) and 25 sensitive (CS-Kp). Table [1](#Tab1){ref-type="table"} shows the entire clinical sample and the departments of isolation. Table 1*K. pneumoniae* CR and CS isolates, department of isolations, host disease, host age and clinical sampleCR-Kp IDDepartmenthost diseasehost ageSampleCS-Kp IDDepartmenthost diseasehost ageSample1 RGeneral surgeries emergenciessepsi70Blood PVC1 SEndocrinology and Metabolic diseasesICU75Urine2 RAnaesthesia and resuscitationsepsi46Blood CVC2 SSurgical OncologyICU81Urine3 RAnaesthesia and resuscitationsepsi59Blood PVC3 SNephrology and HypertensionICU70Urine4 RAnaesthesia and resuscitationpneumoniae60Bronchoalveolar lavage4 SClinical Respiratory MedicineICU64Urine5 RGeneral surgeries emergenciessepsi36Intra-abdominal fluid5 SGeneral and Thoracic SurgeryICU52Wound swab6 RInternal Medicine Cardioangiologysepsi36Blood PVC6 SGeriatric medicineinfected wound21Urine7 RCardiac surgerysepsi53Blood CVC7 SGeriatric medicineICU82Ulcer swab8 RClinical Respiratory MedicineICU77Urine8 SPlastic surgeryinfected wound82Tissue9 RInternal MedicineICU49Urine9 SClinical Respiratory Medicineinfected wound74Urine10 RClinical Respiratory MedicineICU79Urine10 SInternal Medicine CardioangiologyICU76Sputum11 RGeriatric medicineICU90Urine11 SInfectious diseasepneumoniae77Sputum12 REndocrinology and Metabolic diseasesICU84Urine12 SClinical Respiratory Medicinepneumoniae22Bronchoalveolar lavage13 RAnaesthesia and resuscitationsepsi70Blood PVC13 SNICUpneumoniae81Endotracheal tube14 RInternal Medicine Cardioangiologysepsi54CVC14 SHaematology and Bone Marrow Transplantationpneumoniae15 daysSputum15 RCardiac surgerypneumoniae72Bronchoalveolar lavage15 SRheumatologypneumoniae83Urine16 RAnaesthesia and resuscitationICU60Urine16 SInternal MedicineICU73Sputum17 RInternal Medicine Cardioangiologyinfected wound38Ulcer swab17 SGeriatric medicinepneumoniae76Urine18 RInternal Medicine Cardioangiologypneumoniae77Sputum18 SRheumatologyICU36Urine19RCardiac surgeryinfected wound71Wound swab19 SClinical Respiratory MedicineICU91Sputum20 RClinical Respiratory MedicineICU80Urine20 SGeneral surgeries emergenciespneumoniae63Liquor21 RGeneral surgeries emergenciesbile infections65Bile21 SInternal Medicine CardioangiologyMeningitidis92Urine22 RAnaesthesia and resuscitationsepsi70Blood CVC22 SAnaesthesia and resuscitationICU82Urine23 RCardiac surgerypneumoniae62Sputum23 SHaematology and Bone Marrow TransplantationICU70Cutaneous swab24RGeneral surgeries emergenciessepsi72Intra-abdominal fluid24 STourism and Migrationinfected wound81Urine25 RGeneral surgeries emergenciessepsi54Abscess fluid25 SInternal Medicine CardioangiologyICU71UrineCVC: central venous catheter, ICU: intensive care unit, NICU: neonatal intensive care unit, PVC: Peripheral venous catheter

DNA isolation {#Sec4}
-------------

The template DNA was prepared from bacterial colonies grown for 18 h on Blood Agar plates. Colonies were picked and suspended in 500 μl of ultra-pure DNase-free water. The suspension was harvested at 14000 rpm for 10 min. The supernatants were discarded while DNA from the pellets were extracted using the QIAmp® DNA Mini kit *Qiagen* (QIAGEN; Hilden, Germany), the quantity and purity of the DNA were determined using NanoDrop 8000 spectrophotometer (Thermo Fisher Scientific, Waltham).

Whole-genome sequencing {#Sec5}
-----------------------

Isolate's genomes were fully sequenced at the Scientific Department, Army Medical Center, Military Polyclinic of Rome (Italy) using the next-generation sequencing on the Illumina MiSeq platform (San Diego, CA, USA) as recommended by the manufacturer. The library sizes had peaks centered from 900 to 1000 bp.

The reads were de novo assembled into contigs using AByss, version 1.5.2 (k parameter = 63) \[[@CR22]\]. Contigs longer than 500 bp were selected using an ad hoc script and kept for further analysis. The final assembly ranged from 44 to 414 (median: 143) contigs per sample (N50: 335,064--64,441; median: 111,289). Contigs were merged through the Minimus2 software (Sommer et al., 2007) and resulting DNA sequences were analysed for similarity using the database sequences by the Standard Nucleotide BLAST program ([http://blast.ncbi.nlm.nih.gov/Blast.cgi](http://blast.ncbi.nlm.nih.gov/Blast.cgi))). Illumina-generated sequence data for the whole data set of this study have been deposited at NCBI (BioProject id: PRJNA515715 and accession number SUB5047324).

Analysis of virulome and resistome {#Sec6}
----------------------------------

Virulome of all *K. pneumoniae* sample was analysed using the VirulenceFinder-1.4 tool and the Pasteur *K. pneumoniae* database. The resistome of carbapenem-resistant *K. pneumoniae* was analysed using the ResFinder-2.1 software (default identity thresholds \[ID\] 98%) which was provided by the Center for Genomic Epidemiology (<http://www.genomicepidemiology.org>) and the resources of the Pasteur MLST *K. pneumoniae* database.

Multilocus sequence typing (MLST) in silico {#Sec7}
-------------------------------------------

he in silico MLST analysis was made by comparing the whole-genome sequences against the *K. pneumoniae* alleles profiles available at <http://www.pasteur.fr/mlst> (Genotyping of Pathogens and Public Health, Institute Pasteur, Paris, France).

Core single-nucleotide polymorphisms (SNPs) {#Sec8}
-------------------------------------------

Phylogenetic analysis based on genome-wide single nucleotide polymorphisms (SNPs) were conducted detecting SNPs through the kSNP v2.1.2 program (*k*-mer = 21), which defines a SNP locus as an oligo of length *k* surrounding a central SNP allele \[[@CR26]\]. Maximum likelihood tree based on the 57,766 core SNPs identified by kSNP program was visualised using the Dendroscope v3.2.10 software \[[@CR27]\]. Strain 8S, *K. pseudopneumoniae*, was used as outgroup to root the tree.

Statistical analysis {#Sec9}
--------------------

Data were expressed as absolute numbers or percentages. The Chi-squared test was used to compare proportions (as appropriate). Values of *p* \< 0.05 were considered statistically significant. The statistical analysis were performed with MedCalc Statistical software version 16.8 (MedCalc Software bvba, Ostend, Belgium; [https://www.medcalc.org](https://www.medcalc.org/); 2016).

Results {#Sec10}
=======

CR-Kp were mainly isolated from blood and urinary samples (28% for both) (Fig. [1](#Fig1){ref-type="fig"}), while the ward from which CR-Kp was primarily isolated was the Anaesthesia and Resuscitation Department (24%) (Table [1](#Tab1){ref-type="table"}). Regarding CS-Kp, urines were the major isolation sample (52%) (Fig. [1](#Fig1){ref-type="fig"}), while the ward from which CS-Kp was primarily isolated was the Respiratory Department (52%) (Table [1](#Tab1){ref-type="table"}). Fig. 1Samples from where isolated the strains

Antibiotic resistance {#Sec11}
---------------------

The percentages of antibiotic resistance among *K. pneumoniae* carbapenem-resistant and carbapenem-susceptible strains are reported in Table [2](#Tab2){ref-type="table"}. As shown, the CR-Kp group displayed a higher percentage of resistance for all tested antibiotics compared to the susceptible group. Statistical significance was calculated where applicable. In particular, 20% of CR-Kp and 4% of CS-Kp were colistin-resistant. Complete antibiotic resistance profile of CR-Kp are shown in Additional file [1](#MOESM1){ref-type="media"}. Table 2Percentage of antibiotic resistance in carbapenem resistant and susceptible *K. pneumoniae*ClassAntibiotics*K. pneumoniae* CR %*K. pneumoniae* CS %*P* valueAminoglicosydesGentamycin64480.022CarbapenemsImipenem1000NAMeropenem1000NAErtapenem1000NAMonobactamsAztreonam10060NAFluoroquinolonesCiprofloxacin10064NASulfonamides-TrimethoprimTrimethoprim-sulfamethoxazole76600.015PenicillinAmoxicillin/ clavulanic acid10056NAPiperacillin/tazobactam10044NACephalosporinCefotaxime10060NACefuroxime10060NACefepime88560Ceftazidime10060NAFosfomycin c/G6P36160.001TetracyclinTigecyclin840.233Colistin2040NA: chi-squared test not applicable

MLST analysis and Core single-nucleotide polymorphisms (SNPs) phylogenetic analysis {#Sec12}
-----------------------------------------------------------------------------------

MLST in silico analysis of CR-Kp revealed that 52% belonged to CC258. In particular, 5 strains were ST258 (20%) and 8 were ST512 (32%). The remaining 12 strains were distributed as follows: 3 were ST395 (12%), 3 were ST307 (12%), 2 were ST392 (8%), 2 were ST348 (8%), 1 was ST405 (4%) and 1 was ST101 (4%). Among CS-Kp's we detected 14 different STs. ST405 was the most represented (5 strains, 20%), followed by ST392 and ST15 (3 strains, 12%), ST395, ST307 and ST1727 (2 strains, 8%), and one strain each for all other STs. Figure [2](#Fig2){ref-type="fig"} shows ST distribution across the entire sample. Fig. 2Percentage of ST found

The core-SNP phylogenetic analysis showed that strains belonging to the same ST clustered in the same groups, without regard to CR susceptibility or resistance (see Additional file [3](#MOESM3){ref-type="media"}). Moreover, the SNP analysis allows distinguishing each different strain.

Virulome: CR-Kp group versus CS-Kp group {#Sec13}
----------------------------------------

Virulence factors distribution in CR-Kp and CS-Kp is detailed in Table [3](#Tab3){ref-type="table"}. The *mrk* operon, which encodes type 3 fimbriae, was detected in all isolates. The *wzi* gene, involved in the capsule attachment to the host cell surface and used for the prediction of capsular (K) antigen type, was found in all CR-Kp isolates (100%), in particular, 3 strains carried the *wzi-2* allele (see Additional file [4](#MOESM4){ref-type="media"}). Regarding the iron acquisition systems, the distribution of genes encoding for the yersiniabactin system (*ybt*), its receptor fyuA and the aerobactin system did not show significant differences between CR-Kp and CS-Kp (Table [3](#Tab3){ref-type="table"}). *Klebsiella* ferrous iron uptake system (*kfuA, kfuB* and *kfuC* genes), the two-component system *kvg*AS and the microcin E495 were significantly (*p* \< 0.05) prevalent in the CS-Kp group (28%) compared to the CR-Kp one (4%) (Table [3](#Tab3){ref-type="table"}). Table 3Distribution of virulence factors in carbapenem resistant and susceptible *K. pneumoniae* strainsVirulence factorsLocus-Genes*K. pneumoniae* CR\
n (%)*K. pneumoniae* CS\
n (%)P valueType 3 fimbries*mrk* operon25 (100%)25 (100%)1.000Capsule*wzi*25 (100%)23 (92%)0.552Iron acquisition systems*ybt* operon10 (40%)15 (60%)0.089Aerobactin iron acquisition siderophore(*iucABCD*)3 (12%)3 (12%)1.000KlebsiellaFerric ionic-uptake system(*kfuABC*)1 (4%)7 (28%)0.020Two-component systemkvgAS1 (4%)7 (28%)0.020BacteriocinMicrocin E4921 (4%)7 (28%)0.020

Table [4](#Tab4){ref-type="table"} displays the comparative analysis of virulence determinants between CR-Kp and CS-Kp belonging to the same ST. All strains belonging to ST405, regardless of their resistance profile, had the same determinants (*mrk*, *wzi*-143, *ybt*, microcin E495 and *kvg*AS. Regarding the strains belonging to ST307, both CR-Kp and CS-Kp strains had the *mrk* operon, *wz*i-173 and ybt operon, with the exception of the 5R isolate, lacking *ybt* genes (Table [4](#Tab4){ref-type="table"}). Table 4Distribution of virulence determinants in STs clone of *K. pneumoniae* CR and CSSTsCR-KpCS-KpST395*mrk*, *wzi*-2, *ybt*, yuc,*mrk*, *wzi*-2, *ybt*, *yuc*ST307*mrk*, wzi-173 *ybt* ^1^*mrk*, *wzi*-173, *ybt*ST392*mrk*, wzi-187*mrk*, *wzi*-187ST405*mrk*, wzi-143, *ybt*, kvgAS, E495*mrk*, *wzi*-143, *ybt*, kvgAS, E495^1^missing in one of the three CR isolates

Virulome subanalysis by STs across the CR-Kp group {#Sec14}
--------------------------------------------------

CR-Kp isolates belonging to ST512, ST258 did not carry virulence determinants other than *mrk* and *wzi* (Table [4](#Tab4){ref-type="table"}). The three strains belonging to ST395 carried four virulence determinants: *mrk*, *fyu*A/*irp2*, iucABCD and *wzi* type 2. *wzi* gene type 27 was found in the two ST392 isolates together with the *mrk* operon. Strains belonging to ST348 carried the *mrk* operon, *ybt* operon and *wzi*-94 gene, whereas the ST101 strain exhibited *mrk*, *ybt* operon, *wzi* type 17 and the kfuABC system. The ST405 isolate was the only one that carried the kvgAS operon and the microcin E495, together with the *mrk* operon, *ybt* operon and the *wzi-*143.

Resistome analysis across the CR-Kp group {#Sec15}
-----------------------------------------

The in silico β-lactamase characterisation of CR-Kp isolates showed that the most frequent carbapenemase-producing gene was *bla*SHV (100%). In particular, SHV variant 182 was detected in 16 out of 25 isolates (64%), while variant 28 in four strains (16%), three ST307 and the only ST101 isolate. *bla*KPC was identified in 88% of isolates and the most common variant was *bla*KPC-3 (90.9%). *bla*TEM was found in 23 isolates (92%), all of which were variant 1 and *bla*CTX-M (variant 15) was found in 8 isolates (32%). *bla*OXA was found in 22 isolates (88%), 14 of these were variant 9 (63.6%), 5 were variant 1 (22.72%) and 3 isolates (13.63%) presented both variants, *bla*OXA-1 and *bla*OXA-9. Five isolates, one belonging to ST395, two to ST307, one to ST101 and one to ST405 owned all the five carbapenemase-producing genes investigated (Table [5](#Tab5){ref-type="table"}). Complete data from the in silico analysis (e.g. encoding efflux pumps, heavy metal resistance system, genes involved in aminoglycoside and fluoroquinolone resistance) are shown in Additional file [2](#MOESM2){ref-type="media"}. Table 5*K. pneumoniae* CR profile: colistin susceptibility, carbapenemase, ESBL and beta-lactamases genesSTsIDCS (mg/L)bla KPCbla SHVbla CTX-Mbla TEMbla OXAST5126 R\<=13182--197 R\<=13182--198 R\<=13182------11 R\<=13182--1916 R\<=13182--1919 R\> 43182----122 R\<=13182--1925 R\<=13182--19ST25812 R\<=13182--1918 R\<=13182--1921 R\<=13182--1923 R\> 43182--1924 R\<=13182--19ST3952 R\<=13182--1--4 R\<=13182151110 R\<=13182--1--ST3075 R\<=1928151913 R\<=13281511/920 R\> 4 R228--11/9ST3921 R\<=136715193 R\<=1--671511ST 34815 R\> 4 R--81151117 R\<=1--811511ST 1019 R\<=1328--19ST 40514 R\> 4 R3761511/9

Discussion {#Sec16}
==========

The epidemiology of CR-Kp in our geographic area (Palermo, Italy) has already been characterized in the late 2008 at the emergence of CR-Kp ST258 clones \[[@CR20]\]. However, several reports have suggested an ongoing epidemiological change in the last years. In fact, whereas CC258 (ST258 and ST512) is still prevalent, several other STs are emerging and circulating \[[@CR23], [@CR24], [@CR28]\].

This study set out with the aim of assessing the current dissemination and genetic characteristics of *K. pneumoniae* in Palermo. Even though a larger sample may have allowed to gain more representative data, our preliminary data reveal a complex situation characterized by: 1) high genome "plasticity" of both CR-Kp and CS-Kp, due to the presence of several virulence and resistance determinants carried by mobile genetic elements; 2) a CR-Kp group showing an important genetic diversity of lineages, with 8 different STs identified; 3) an overlapping of multi-drug resistance and hyper virulence traits in the CR-Kp group.

Regarding STs, our comprehensive analysis indicates that, although ST258 and ST512 remain the most representative ones, other STs (e.g. ST307, ST395, ST392, ST348, ST405 and ST101) have been detected in our area. These results are consistent with the surveillance data from other authors \[[@CR20]--[@CR24], [@CR28]\]. Moreover, our findings on β-lactamase characterisation showed that the *bla*SHV gene was the most commonly found in our sample, followed by *bla*TEM and *bla*KPC, deviating from other studies \[[@CR11], [@CR29], [@CR30]\], while respect to the KPC-type enzyme our results are in line with those of other studies - as the most commonly encountered is *bla*KPC-3 \[[@CR21], [@CR23], [@CR31]--[@CR33]\]. Regarding STs, the most represented across the CR-Kp group were ST512 and ST258. These isolates did not carry any distinguishing virulence determinant (except for the *mrk* operon and *wzi* gene, which were present in all the samples), suggesting that the success of these clones may only depend on the acquisition of the *bla*KPC gene \[[@CR9], [@CR15], [@CR34]\].

Among the ST512 isolates, we found the 19R strain profile to be particularly interesting. This colistin-resistant strain was the only one in its ST group that showed both the yersiniabactin system and its receptor, which has been detected in several *K. pneumoniae* MDR clones; despite of this, the clinical effect of the yersiniabactin system on CR-Kp infections has not been clearly determined \[[@CR4], [@CR35], [@CR36]\].

Our data also match those of reports suggesting the recent spread of the well-known clone ST307. In fact, in 2014, a CR-Kp ST307 clone carrying the *bla*KPC-3, coproducing the *bla*CTX-M-15, has been isolated in three Palermo's Hospitals \[[@CR23]\]. The virulome analysis of our ST307 strains has revealed, that 5R isolate was the only one missing the yersiniabactin locus in its ST group. Furthermore, 13R and 5R isolates, two of the three strains belonging to ST307, showed the co-presence of all five carbapenem resistance genes analysed. The co-presence of the detected virulence factors together with the MDR phenotype may explain the diffusion of this clone and the severity of its infections, which have been reported as characterised by higher mortality rates (over 50%) compared to other clones \[[@CR37], [@CR38]\]. Moreover, leaving aside specific considerations about the clone ST307, the co-presence of five carbapenem resistance genes that we detected in five strains of our sample (20%) is in line with that of a study by Ferreira et al., which has recently reported that 72% of the *K. pneumoniae* isolated from a Brazilian Intensive care Unite co-produced *bla*KPC, *bla*OXA, *bla*TEM, *bla*SHV, and *bla*CTX-M \[[@CR39]\].

Another emerging clone, already isolated by other authors in Palermo and also detected in our CR-Kp sample, was the ST395 \[[@CR40]\]. Strains belonging to this clone presented the *wzi*2 allele, which encodes the type K2 capsular antigen that represents one of the most virulent serotypes, thus defined "more virulent" \[[@CR41], [@CR42]\]. CR-Kp ST395 strains also carried the yersiniabactin system and its receptor and were the only resistant isolates to possess the aerobactin system (iucABCD). Two aspects of these strains should be addressed here: i) 4R isolate showed the co-presence of five carbapenem resistance genes; ii) to the best of our knowledge, this is the first time that a CR-Kp ST395 clone is reported as carrying a type 2 capsule. This finding was unexpected and seems to be in contrast with the concept that MDR and hyper virulent clonal complexes do not normally overlap \[[@CR42]\].

Moreover, our data confirm the spreading of the ST392 clone. A recently published study by Di Mento and colleagues has reported, for the first time, the isolation of a *K. pneumoniae* strain ST392 *bla*KPC-3 carrying the *bla*CTX-M-15, *bla*SHV-11 and *bla*TEM-1 genes from a patient in Palermo who had undergone kidney-pancreas transplantation \[[@CR43]\]. In our CR-Kp ST392 sample, the 1R strain which was isolated from blood at the General and Emergency Surgery Department in 2015, showed the co-existence of *bla*KPC-3, *bla*SHV-67, *bla*CTX-M-15, *bla*TEM-1 and *bla*OXA-9. This result is interesting as the only other KPC-producing *K. pneumoniae* ST392 ever reported was isolated in China but with a different isoform, KPC-2 \[[@CR44]\]. However, it is important to underline that the other ST392 strain (3R) in our CR-Kp sample did not carry the *bla*KPC gene, suggesting that the ST392 KPC-3 clone may have acquired the resistance gene through horizontal transmission, as described by other authors \[[@CR43]\].

This study also revealed two MDR CR-Kps belonging to ST348 and carrying the *bla*CTX-M-15, *bla*SHV-81, *bla*TEM-1 and *bla*OXA-1 genes. Strains belonged to ST348, but harboured the *bla*KPC-3, which had been previously reported as responsible of several epidemic events in Portugal \[[@CR45]\]. Considering that one of our isolates was colistin-resistant and the ease with which *K. pneumoniae* acquires the *bla*KPC gene, we can consider the MDR CR-Kp ST348 strains as possibly emerging high-risk clones.

Three other important data that emerge from our results and complete the description of the CR-Kp epidemiological scene in Palermo are: firstly, the circulation of strains belonging to ST101. This clone was previously recognized worldwide as a high risk carbapenem-producing clone \[[@CR30]\] and has already been identified in Palermo and in the North of Italy \[[@CR46]--[@CR48]\]. Our ST101 strain (9R) carried the *bla*KPC-3, *bla*SHV-28, *bla*TEM-1 and *bla*OXA-9 genes and the *Klebsiella* ferrous uptake system, which is typically found in *K. pneumoniae* hypervirulent strains \[[@CR49], [@CR50]\]; secondly, the characteristic of the strain belonging to ST405, which carried the *bla*KPC-3, *bla*CTX-15, *bla*SHV-76, *bla*TEM-1 and *bla*OXA-1/9 genes, the *aac6-Ib-cr* and *qnrB* and was resistant to colistin. Strains from ST405 have similarly caused an outbreak in a Spanish Hospital neonatal unit \[[@CR50]\] and have already been isolated in Palermo \[[@CR24]\]. It is important to underline that the genes involved in microcin production and kvgA/S system were detected in all isolates belonging to ST405, both resistant and susceptible to carbapenem, possibly indicating a stable and characteristic genetic pattern for these clones; lastly to the best of our knowledge this is the first study to report in Italy the isolation of five CR-Kp isolates belonging to different STs showing the co-presence of five carbapenem resistance genes.

Conclusions {#Sec17}
===========

These results are significant in at least two major respects. Overall, this study strengthens the idea that the epidemiological frame in the Palermo area (Sicily, Italy) is shifting and new MDR clones are emerging. However, our analysis, which included the comparison of the virulence degree of CS-Kp and CR-Kp isolates, has unexpectedly revealed that the latter are acquiring highly-virulent determinants and the co-presence of more resistance genes. Undoubtedly, since co-existence of antibiotic resistance and virulence factors may lead to life-threatening untreatable and invasive *K. pneumoniae* infections, this is an important issue to take into consideration for future genomic surveillance studies.
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